Department of Nursing, Faculty of Medicine, Universitat Autònoma de Barcelona, Can Domènech, Edifici M, Campus de la Universitat Autònoma de Barcelona, 08193, Bellaterra (Cerdanyola del Vallès), Barcelona, Spain.
Grup de REcerca Multidisciplinar en Salut i Societat (GREMSAS), (2017 SGR 917), Barcelona, Spain.
Health Care Anal. 2023 Dec;31(3-4):135-155. doi: 10.1007/s10728-023-00461-z. Epub 2023 Jul 21.
The informed consent is an ethical and legal requirement for potential participants to enroll in a study. There is ample of evidence that understanding consent information and enrollment is challenging for participants in clinical trials. On the other hand, the reasoning process behind decision-making in HIV clinical trials remains mostly unexplored. This study aims to examine the decision-making process of people living with HIV currently participating in antiretroviral clinical trials and their understanding of informed consent. We conducted a qualitative socio-constructivist study using semi-structured interviews. Eleven participants were selected by purposive sampling in Argentina until data saturation was reached. A content analysis was performed. The findings highlight the fact that some participants decided to enroll on the spot, while others made the decision a few days later. In all cases, the decision was based on different aspects of trust (in doctors, in the clinical research site, in the clinical trials system) but also on emotions associated with HIV and/or treatment. Moreover, while people living with HIV felt truly informed after the consent dialogue with a researcher, consent forms were unintelligible and unfriendly. The immediacy of patient decision-making has rarely been described before. Enrollment in an HIV clinical trial is mainly a trust-based decision but this does not contradict the ethical values of autonomy, voluntariness, non-manipulation, and non-exploitation. Thus, trust is a key issue to be included in reshaping professional practices to ensure the integrity of the informed consent process.
知情同意是潜在参与者参与研究的伦理和法律要求。有充分的证据表明,临床试验参与者理解同意信息和参与是具有挑战性的。另一方面,HIV 临床试验决策背后的推理过程在很大程度上仍未得到探索。本研究旨在检查目前参与抗逆转录病毒临床试验的 HIV 感染者的决策过程及其对知情同意的理解。我们使用半结构式访谈进行了定性的社会建构主义研究。在阿根廷,通过目的性抽样选择了 11 名参与者,直到达到数据饱和。进行了内容分析。研究结果强调了一个事实,即一些参与者当场决定参加,而另一些则在几天后做出决定。在所有情况下,决定都是基于不同方面的信任(对医生、临床研究地点、临床试验系统的信任),但也基于与 HIV 和/或治疗相关的情绪。此外,虽然 HIV 感染者在与研究人员进行同意对话后感到真正知情,但同意书却难以理解且不友好。患者决策的即时性以前很少被描述过。参加 HIV 临床试验主要是基于信任的决定,但这并不违背自主、自愿、非操纵和非剥削的伦理价值观。因此,信任是一个关键问题,需要纳入重塑专业实践,以确保知情同意过程的完整性。